Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Smoking cessation treatment launched in the U.S.

July 10, 1997

Tolerance to benzodiazepine hypnotics overcome with melatonin

June 6, 1997

DynaGen licenses smoking cessation technology

June 6, 1997

FDA clears Glaxo Wellcome's aid to smoking cessation

May 16, 1997

ImmuLogic receives funds from NIH to develop cocaine vaccine

May 12, 1997

Nicotine inhaler cleared by FDA

May 7, 1997

Alza and SmithKline Beecham sign new agreement for Nicoderm

April 22, 1997

Ibogamine congeners for addiction

April 15, 1997

Allelix and Pharm-Eco create partnership

April 10, 1997

PDL and Teijin agreement for MAb to E. coli toxin

April 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 2, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
Filling the NIH funding gap to protect biopharma research
BioWorld
The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...